Home | Welcome to Contract Pharma   
Last Updated Wednesday, July 23 2014
Print RSS Feed

India Report

S. Harachand, Contributing Editor
July 21, 2014
As they focus on generic biologics, Indian firms are setting their sights on monoclonal antibodies  Read More »
S. Harachand, Contributing Editor
June 3, 2014
The government is scrutinizing the way that severe adverse effects are reported, and revisiting fnancial compensation requirements  Read More »
S. Harachand, Contributing Editor
May 1, 2014
Indian CMOs are targeting new global markets. API supplier Aurobindo, through its acquisition of Actavis assets, is moving into finished generics in Western Europe.  Read More »
S. Harachand, Contributing Editor
April 3, 2014
Bridging the gap between formulation and tablet manufacturing, pharmaceutical formulation intermediate (PFI) outsourcing promises sponsors time and cost reduction  Read More »
S. Harachand, Contributing Editor
March 7, 2014
Drug discovery has turned into a hot topic in the world’s generic powerhouse. The immediate trigger for this spurt in interest is Biocon’s recent launch of a trastuzumab biosimilar. Developed in partnership with Mylan, the ‘cost-eff…  Read More »
S. Harachand, Contributing Editor
January 24, 2014
Clinical research continues to remain at the top of the news, courtesy of the Supreme Court of India. Through a series of judgments delivered on an ongoing litigation, the apex judiciary has directed the drug regulatory body to get its act together t…  Read More »
S. Harachand, Contributing Editor
November 13, 2013
Injectables CMOs steal the show   Read More »
S. Harachand, Contributing Editor
October 9, 2013
Will CROs need accreditation for approval?  Read More »
S. Harachand, Contributing Editor
September 5, 2013
After GDUFA, will CMOs rethink their strategies?  Read More »
S. Harachand, Contributing Editor
July 17, 2013
Tightening norms for exports, imports  Read More »
S. Harachand, Contributing Editor
June 5, 2013
India has rolled out a series of measures to streamline the country’s clinical research industry in recent years. Regulatory activity reached its peak recently with some bold steps, like compulsory registration of institutional ethical committe…  Read More »
S. Harachand, Contributing Editor
May 6, 2013
Limit the verdict to Glivec  Read More »
S. Harachand, Contributing Editor
April 3, 2013
APIs behind big buys   Read More »
S. Harachand, Contributing Editor
March 6, 2013
Law turns tough on the errants  Read More »
S. Harachand, Contributing Editor
January 22, 2013
Injectables steal the show  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On